{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T20:25:12Z","timestamp":1787430312986,"version":"build-2736575974"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100023938","name":"Mallinckrodt Institute of Radiology, School of Medicine, Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023938","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007930","name":"University of Missouri Clinical & Translational Science Unit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007930","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.acra.2026.05.017","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:45:55Z","timestamp":1781754355000},"page":"3658-3666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Implementation of a New MRI Contrast Policy at a Large Hospital System: Access to Contrast-Enhanced MRI and Development of NSF in Patients with Renal Insufficiency"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8131-3003","authenticated-orcid":false,"given":"Daniel R.","family":"Ludwig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Minor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammie L.S.","family":"Benzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anup S.","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.acra.2026.05.017_bib1","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/j.sult.2019.12.005","article-title":"Risks and benefits of gadolinium-based contrast-enhanced MRI","volume":"41","author":"Costelloe","year":"2020","journal-title":"Semin Ultrasound CT MRI"},{"issue":"2","key":"10.1016\/j.acra.2026.05.017_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1148\/radiol.2502080498","article-title":"Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases","volume":"250","author":"Perez-Rodriguez","year":"2009","journal-title":"Radiology"},{"issue":"9","key":"10.1016\/j.acra.2026.05.017_bib3","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1681\/ASN.2006060601","article-title":"Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging","volume":"17","author":"Marckmann","year":"2006","journal-title":"J Am Soc Nephrol JASN"},{"key":"10.1016\/j.acra.2026.05.017_bib4","series-title":"New warnings for using gadolinium-based contrast agents in patients with kidney dysfunction. FDA","author":"FDA Drug Safety Communication","year":"2019"},{"issue":"2","key":"10.1016\/j.acra.2026.05.017_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/jmri.25625","article-title":"Gadolinium-based contrast agents: a comprehensive risk assessment","volume":"46","author":"Fraum","year":"2017","journal-title":"J Magn Reson Imaging JMRI"},{"key":"10.1016\/j.acra.2026.05.017_bib6","unstructured":"ACR Manual on Contrast Media, Version 2025. https:\/\/www.acr.org\/-\/media\/ACR\/Files\/Clinical- Resources\/Contrast_Media.pdf. Accessed October 8, 2025."},{"issue":"2","key":"10.1016\/j.acra.2026.05.017_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2019.5284","article-title":"Risk of nephrogenic systemic fibrosis in patients with stage 4 or 5 chronic kidney disease receiving a group II gadolinium-based contrast agent: a systematic review and meta-analysis","volume":"180","author":"Woolen","year":"2020","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.acra.2026.05.017_bib8","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1148\/radiol.2020202903","article-title":"Use of intravenous gadolinium-based contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation","volume":"298","author":"Weinreb","year":"2021","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.acra.2026.05.017_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/RLI.0000000000000145","article-title":"Nephrogenic systemic fibrosis risk after liver magnetic resonance imaging with gadoxetate disodium in patients with moderate to severe renal impairment","volume":"50","author":"Lauenstein","year":"2015","journal-title":"Invest Radiol"},{"issue":"3","key":"10.1016\/j.acra.2026.05.017_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2214\/AJR.14.14268","article-title":"Prospective cohort study of nephrogenic systemic fibrosis in patients with stage 3-5 chronic kidney disease undergoing MRI with injected gadobenate dimeglumine or gadoteridol","volume":"205","author":"Soulez","year":"2015","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1016\/j.acra.2026.05.017_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/RLI.0000000000000259","article-title":"Incidence of nephrogenic systemic fibrosis using gadobenate dimeglumine in 1423 patients with renal insufficiency compared with gadodiamide","volume":"51","author":"Bruce","year":"2016","journal-title":"Invest Radiol"},{"issue":"2","key":"10.1016\/j.acra.2026.05.017_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1148\/radiol.2020201492","article-title":"Risk of nephrogenic systemic fibrosis in stage 4 and 5 chronic kidney disease following group II gadolinium-based contrast agent administration: subanalysis by chronic kidney disease stage","volume":"297","author":"Shankar","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.acra.2026.05.017_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jmri.26851","article-title":"Observational study on the incidence of nephrogenic systemic fibrosis in patients with renal impairment following gadoterate meglumine administration: the NSsaFe study","volume":"51","author":"McWilliams","year":"2020","journal-title":"J Magn Reson Imaging JMRI"},{"key":"10.1016\/j.acra.2026.05.017_bib14","first-page":"153","article-title":"Gadolinium Deposition and Nephrogenic Systemic Fibrosis: A Radiologist\u2019s Primer","volume":"40","author":"Mathur","year":"2020"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226004137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633226004137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T19:57:27Z","timestamp":1787428647000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633226004137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1076633226004137"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2026.05.017","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementation of a New MRI Contrast Policy at a Large Hospital System: Access to Contrast-Enhanced MRI and Development of NSF in Patients with Renal Insufficiency","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2026.05.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Association of Academic Radiology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}